* Prophase Labs Inc PRPH.OQ PRPH.O is expected to show a
fall
in quarterly revenue when it reports results on March 28.
* The New York City-based company is expected to report a
54.6% decrease in revenue to $20.513 million from $45.16 million
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data.
* Refinitiv's mean analyst estimate for Prophase Labs Inc
is for
earnings of 3 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prophase
Labs Inc
is $15.5, above its last closing price of $7.48.
This summary was machine generated March 24 at 13:04 GMT. All
figures in US dollars unless otherwise stated